Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asklepios BioPharmaceutical, Inc.

https://www.askbio.com/

Latest From Asklepios BioPharmaceutical, Inc.

Bayer Puts Spotlight On Pharma Pipeline

The Leverkusen-based firm has been touting the potential of its pharmaceutical pipeline which it hopes will be able to help soften the blow of patent expiries on the blockbusters Xarelto and Eylea in the next few years.

Gene Therapy Strategy

Senti Bio Raises $105m Series B Round For CAR-NKs, Led By Leaps For Bayer

The investment is the latest in Bayer’s series of moves into cell and gene therapy, amid growing industry interest in CAR-NKs.

BioPharmaceutical Cancer

Bayer Bids To Be A Winner In Cell & Gene Therapy

The last six weeks have seen the acquisition of AskBio, the launch of a dedicated cell and gene therapy unit and a CAR-T pact with Atara. Bayer is taking the space very seriously.

Gene Therapy Leadership

Bayer Enters CAR-T Space With Atara Pact

Marianne De Backer, head of pharma BD and licensing at the German firm, told Scrip, "We strongly believe that the future is allogeneic and we were looking for pioneers in the field."

Cancer Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Tools
      • Bioinformatics
  • Other Names / Subsidiaries
    • Actus Therapeutics, Inc.
    • AskBio
    • Synpromics, Ltd.
    • RoverMed BioSciences
    • NanoCor Therapeutics
    • BrainVectis
UsernamePublicRestriction

Register